Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The potential role of targeted therapies in the management of neuroendocrine tumours.
Verset G, Borbath I, Delaunoit T, Demetter P, Demolin G, Hendlisz A, Pattyn P, Pauwels S, Peeters M, Roeyen G, Van Cutsem E, Van Hootegem P, Verslype C, Van Laethem JL. Verset G, et al. Among authors: van cutsem e, van hootegem p, van laethem jl. Acta Gastroenterol Belg. 2009 Jan-Mar;72(1):59-62. Acta Gastroenterol Belg. 2009. PMID: 19402374 Review.
Adjuvant treatment for colorectal cancer.
Van Laethem JL. Van Laethem JL. Acta Gastroenterol Belg. 2001 Jul-Sep;64(3):263-7. Acta Gastroenterol Belg. 2001. PMID: 11680045 Review.
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study.
Demols A, Peeters M, Polus M, Honoré P, Boterberg T, Gay F, Closon MT, Van Houtte P, Closset J, Van Laethem JL. Demols A, et al. Among authors: van houtte p, van laethem jl. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1351-6. doi: 10.1016/j.ijrobp.2005.01.043. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029792 Clinical Trial.
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Van Cutsem E, Peeters M, Siena S, Humblet Y, Hendlisz A, Neyns B, Canon JL, Van Laethem JL, Maurel J, Richardson G, Wolf M, Amado RG. Van Cutsem E, et al. Among authors: van laethem jl. J Clin Oncol. 2007 May 1;25(13):1658-64. doi: 10.1200/JCO.2006.08.1620. J Clin Oncol. 2007. PMID: 17470858 Clinical Trial.
Emerging drugs for the treatment of pancreatic cancer.
Van Laethem JL, Marechal R. Van Laethem JL, et al. Expert Opin Emerg Drugs. 2007 May;12(2):301-11. doi: 10.1517/14728214.12.2.301. Expert Opin Emerg Drugs. 2007. PMID: 17604503 Review.
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
Tabernero J, Van Cutsem E, Díaz-Rubio E, Cervantes A, Humblet Y, André T, Van Laethem JL, Soulié P, Casado E, Verslype C, Valera JS, Tortora G, Ciardiello F, Kisker O, de Gramont A. Tabernero J, et al. Among authors: van cutsem e, van laethem jl. J Clin Oncol. 2007 Nov 20;25(33):5225-32. doi: 10.1200/JCO.2007.13.2183. J Clin Oncol. 2007. PMID: 18024868 Clinical Trial.
269 results